Improving Stroke Outcomes - New Targets and Therapies

Hankey, Graeme (Chief Investigator)

Status	Finished
Effective start/end date	1/01/07 → 31/12/11

Funding

NHMRC National Health and Medical Research Council

Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack
Brookes, R. L., Crichton, S., Wolfe, C. D. A., Yi, Q., Li, L., Hankey, G. J., Rothwell, P. M. & Markus, H. S., 1 Jan 2018, In: Stroke. 49, 1, p. 54-61 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
68 Link opens in a new tab Citations (Scopus)